Urell and Pregnancy

Urinary Tract Infection (UTI) Clinical Trial

Official title:

Effect of URELL(Cranberry Vaccinium Macrocarpon)Consumption on the Prevalence of Recurrent Urinary Tract Infection and Asymptomatic Bacteriuria During Pregnancy.

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT01818180
• Other study ID #: 2009/19
• Status: Terminated
• Phase: N/A
• First received: March 19, 2013
• Last updated: March 21, 2013
• Start date: May 2010

Study information

• Verified date: March 2013
• Source: Hopital Foch
• Contact: n/a
• Is FDA regulated: No
• Health authority: France : Agence Française de Sécurité Sanitaire des Produits de Santé
• Study type: Interventional

Clinical Trial Summary

Evaluation of the effect of URELL consumption on the occurrence of recurrent urinary tract infection (Acute cystitis, pyelonephritis and asymptomatic bacteriuria).

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 11
• Est. primary completion date: September 2012
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years to 40 Years

Eligibility

Inclusion Criteria:

• Pregnant woman in her 4th gestational month or more, having urinary tract infection.

Exclusion Criteria:

• Pregnant woman with organic or functional urinary tract malformations

• Diabetic patients

• HIV positive

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Masking: Double Blind (Subject, Investigator)

Related Conditions & MeSH terms

• Urinary Tract Infection (UTI)
• Urinary Tract Infections

Intervention

Dietary Supplement:
• URELL

Other:
• Placebo

Locations

Country	Name	City	State
France	Hôpital FOCH	Suresnes

Sponsors (1)

Lead Sponsor	Collaborator
Hopital Foch

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Recurrence of Urinary tract infections		From the 4th gestational month till the end of pregnancy (about the 40th gestational week)	No